Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
Scope of the Report:
The classification of Transcatheter Aortic Valve Replacement (TAVR) includes transfemoral approach, transapical approach and others. The proportion of transfemoral approach in 2017 is about 83%.
Transcatheter Aortic Valve Replacement (TAVR) is widely used for aortic stenosis, aortic regurgitation and other diseases. The most proportion of Transcatheter Aortic Valve Replacement (TAVR) is used for aortic regurgitation, and the proportion in 2017 is 76%.
Europe is the largest consumption place, with a consumption market share nearly 52% in 2017. Following Europe, North America is the second largest consumption place with the consumption market share of 40%.
The global Transcatheter Aortic Valve Replacement (TAVR) market is valued at 3130 million USD in 2018 and is expected to reach 10700 million USD by the end of 2024, growing at a CAGR of 22.8% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Transcatheter Aortic Valve Replacement (TAVR).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Transcatheter Aortic Valve Replacement (TAVR) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Transcatheter Aortic Valve Replacement (TAVR) market by product type and applications/end industries.
Market Segment by Companies, this report covers
St. Jude Medical
Meril Life Sciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into